These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6104444)

  • 21. Toward an integrated approach to the treatment of schizophrenia.
    Herz MI
    Psychother Psychosom; 1986; 46(1-2):45-57. PubMed ID: 2885894
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intermittent medication for stable schizophrenic outpatients: an alternative to maintenance medication.
    Herz MI; Szymanski HV; Simon JC
    Am J Psychiatry; 1982 Jul; 139(7):918-22. PubMed ID: 6124133
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Longterm treatment of schizophrenia].
    Pajonk VF
    MMW Fortschr Med; 2006 Jan; 148(4):35-8. PubMed ID: 16502798
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relapse of psychiatric patients in foster care.
    Linn MW; Klett CJ; Caffey EM
    Am J Psychiatry; 1982 Jun; 139(6):778-83. PubMed ID: 6123264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of a cognitive behaviourally oriented service for relapse prevention in schizophrenia.
    Klingberg S; Wittorf A; Fischer A; Jakob-Deters K; Buchkremer G; Wiedemann G
    Acta Psychiatr Scand; 2010 May; 121(5):340-50. PubMed ID: 19895624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Measuring remission in schizophrenia: response to Sethuraman et al., 2005.
    Kujawa M; Bossie CA; Lasser RA
    Schizophr Res; 2006 Mar; 83(1):109-10. PubMed ID: 16423505
    [No Abstract]   [Full Text] [Related]  

  • 27. Paths to relapse: possible transactional processes connecting patient illness onset, expressed emotion, and psychotic relapse.
    Nuechterlein KH; Snyder KS; Mintz J
    Br J Psychiatry Suppl; 1992 Oct; (18):88-96. PubMed ID: 1389047
    [No Abstract]   [Full Text] [Related]  

  • 28. Prevention of relapse in chronic schizophrenic patients.
    Hogarty GE
    J Clin Psychiatry; 1993 Mar; 54 Suppl():18-23. PubMed ID: 8097193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relapse prevention and recovery in the treatment of schizophrenia.
    Schooler NR
    J Clin Psychiatry; 2006; 67 Suppl 5():19-23. PubMed ID: 16822093
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early, targeted pharmacotherapeutic intervention in schizophrenia.
    Carpenter W
    J Clin Psychiatry; 1986 May; 47 Suppl():23-9. PubMed ID: 2871012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Psychoeducation of patients and their family members during episode psychosis].
    Hodé Y
    Encephale; 2013 Sep; 39 Suppl 2():S110-4. PubMed ID: 24084420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Do neuroleptics prevent relapse? Clinical observations in a psychosocial rehabilitation program.
    Easton K; Link I
    Psychiatr Q; 1986-1987 Spring; 58(1):42-50. PubMed ID: 2879301
    [No Abstract]   [Full Text] [Related]  

  • 33. Are there clinically useful predictors and early warning signs for pending relapse?
    Gaebel W; Riesbeck M
    Schizophr Res; 2014 Feb; 152(2-3):469-77. PubMed ID: 23978776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vulnerability to relapse in schizophrenia.
    Zubin J; Steinhauer SR; Condray R
    Br J Psychiatry Suppl; 1992 Oct; (18):13-8. PubMed ID: 1356362
    [No Abstract]   [Full Text] [Related]  

  • 35. Family management in the prevention of exacerbations of schizophrenia: a controlled study.
    Falloon IR; Boyd JL; McGill CW; Razani J; Moss HB; Gilderman AM
    N Engl J Med; 1982 Jun; 306(24):1437-40. PubMed ID: 6123079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antipsychotic drug treatment in the prodromal phase of schizophrenia.
    Cannon TD; Huttunen MO; Dahlström M; Larmo I; Räsänen P; Juriloo A
    Am J Psychiatry; 2002 Jul; 159(7):1230-2. PubMed ID: 12091205
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coping with symptoms of relapse in schizophrenia.
    Kumar S; Thara R; Rajkumar S
    Eur Arch Psychiatry Neurol Sci; 1989; 239(3):213-5. PubMed ID: 2598967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reducing the dose of depot neuroleptics in stable schizophrenia.
    Dale R; Longdon M; Seeman MV
    J Psychiatry Neurosci; 1994 Jul; 19(4):278-81. PubMed ID: 7918349
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [French Society for Biological Psychiatry and Neuropsychopharmacology task force: Formal Consensus for the prescription of depot antipsychotics].
    Samalin L; Abbar M; Courtet P; Guillaume S; Lancrenon S; Llorca PM
    Encephale; 2013 Dec; 39 Suppl 4():189-203. PubMed ID: 24373464
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prognosis of schizophrenia from the viewpoint of patients and relatives. An explorative study].
    Holzinger A; Müller P; Priebe S; Angermeyer MC
    Psychiatr Prax; 2002 Apr; 29(3):154-9. PubMed ID: 11961717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.